Just for the record, the same is true for all bio companies that have SUCCESSES in phase 1, 2, or 3 studies. Therefore, your observation is meaningless.
Really? ALL of them? OK, then guess what... "all bio companies that have also succeeded in phase 1, 2, or 3 studies had significant efficacy in the same stage NNVC is at, FYI".
Equally true, if you expect your original statement to be taken seriously.
Just to be fair, I'm sure you meant to point that out. :)
Stating the ovidius. By definition they would not have reached the later stages without positive results at the early stage. What you are trying to say is that the fact that they have been positive at this stage does not mean that they will not fail later. But surely everyone already knows that
Market Data 
Markets 
AI
